How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

Incyte is seeking collaborations in HIV, oncology, diabetes, inflammation

Organization name

Incyte Corp. business development

Profile

Incyte's vision is to become a leading drug discovery and development company by building a proprietary product pipeline of novel small molecule drugs. They have an experienced management and discovery team. Their assets, experience and prior success in bringing important new drugs to market puts them in a strong position to make a difference in healthcare, improve the lives of patients and build significant sustainable value for their shareholders.

To succeed in their objective to create a pipeline of novel, orally available drugs that address serious unmet medical needs, they have established a broad range of discovery capabilities in-house, including target validation, high-throughput screening, medicinal chemistry, computational chemistry, and pharmacological and ADME (absorption, distribution, metabolism and excretion) assessment. They augment these capabilities through collaborations with academic and contract laboratory resources with relevant expertise. 

They select drug targets with strong preclinical or clinical validation in areas where they have the potential to generate either first-in-class molecules or compounds that are highly differentiated from existing treatments.

Focus of interest are:

  • HIV
  • diabetes
  • inflammation
  • oncology

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries